Pritesh Shah Novo Cure LTD (NVCR) insider trading activity

Pritesh Shah is Chief Growth Officer of NovoCure Ltd. Currently has a direct ownership of 124,511 shares of NVCR, which is worth approximately $3.82 Million. The most recent transaction as insider was on Nov 07, 2023, when has been sold 382 shares (Ordinary Shares) at a price of $12.65 per share, resulting in proceeds of $4,832. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 125K

0% 3M change

0% 12M change

Total Value Held $3.82 Million

Pritesh Shah Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 07 2023	SELL Open market or private sale	$4,832 $12.65 p/Share	382 Reduced 0.31%	124,511 Ordinary Shares
Sep 01 2023	SELL Open market or private sale	$5,956 $21.82 p/Share	273 Reduced 0.22%	124,893 Ordinary Shares
Jun 30 2023	BUY Grant, award, or other acquisition	$12,947 $35.28 p/Share	367 Added 0.29%	125,166 Ordinary Shares
Mar 03 2023	SELL Open market or private sale	$1,631,423 $76.16 p/Share	21,421 Reduced 14.65%	124,799 Ordinary Shares
Mar 03 2023	BUY Grant, award, or other acquisition	-	47,182 Added 24.4%	146,220 Ordinary Shares
Mar 02 2023	SELL Open market or private sale	$70,537 $75.28 p/Share	937 Reduced 0.94%	99,038 Ordinary Shares
Mar 01 2023	SELL Open market or private sale	$146,840 $76.36 p/Share	1,923 Reduced 1.89%	99,975 Ordinary Shares
Feb 28 2023	BUY Grant, award, or other acquisition	-	19,055 Added 15.75%	101,898 Ordinary Shares
Jan 05 2023	SELL Open market or private sale	$41,796 $108.0 p/Share	387 Reduced 0.46%	82,843 Ordinary Shares
Sep 02 2022	SELL Open market or private sale	$21,262 $79.04 p/Share	269 Reduced 0.32%	83,230 Ordinary Shares
Jul 05 2022	BUY Grant, award, or other acquisition	$18,433 $59.08 p/Share	312 Added 0.37%	83,499 Ordinary Shares
Mar 09 2022	SELL Open market or private sale	$261,196 $71.19 p/Share	3,669 Reduced 4.22%	83,187 Ordinary Shares
Mar 08 2022	SELL Open market or private sale	$173,918 $70.1 p/Share	2,481 Reduced 2.94%	81,908 Ordinary Shares
Mar 07 2022	SELL Open market or private sale	$368,198 $69.55 p/Share	5,294 Reduced 5.9%	84,389 Ordinary Shares
Mar 04 2022	SELL Open market or private sale	$326,766 $71.88 p/Share	4,546 Reduced 4.82%	89,683 Ordinary Shares
Mar 03 2022	SELL Open market or private sale	$74,276 $74.5 p/Share	997 Reduced 1.05%	94,229 Ordinary Shares
Mar 03 2022	BUY Grant, award, or other acquisition	-	21,714 Added 18.57%	95,226 Ordinary Shares
Sep 03 2021	SELL Open market or private sale	$69,754 $139.23 p/Share	501 Reduced 0.68%	73,512 Ordinary Shares
Sep 02 2021	SELL Open market or private sale	$21,564 $138.23 p/Share	156 Reduced 0.21%	74,013 Ordinary Shares
Aug 04 2021	SELL Open market or private sale	$306,789 $148.71 p/Share	2,063 Reduced 2.71%	74,169 Ordinary Shares
Aug 03 2021	SELL Open market or private sale	$247,157 $149.43 p/Share	1,654 Reduced 2.12%	76,232 Ordinary Shares
Jul 31 2021	BUY Exercise of conversion of derivative security	$572,455 $154.01 p/Share	3,717 Added 4.16%	85,625 Ordinary Shares
Jul 06 2021	BUY Grant, award, or other acquisition	$21,116 $137.12 p/Share	154 Added 0.2%	77,886 Restricted Share Units
Jun 10 2021	SELL Open market or private sale	$5,061,100 $215.0 p/Share	23,540 Reduced 23.24%	77,732 Ordinary Shares
May 05 2021	SELL Open market or private sale	$257,574 $199.67 p/Share	1,290 Reduced 1.26%	101,272 Ordinary Shares

Pritesh Shah

Chief Growth Officer

Malvern, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NVCR shares.

Notify only if

Value

Insider Trading

Get notified when an Novo Cure LTD insider buys or sells NVCR shares.

Notify only if

Operation

Value

Type

News

Receive news related to NovoCure Ltd

Track Activities on NVCR

Account